Roostaei T, De Jager PL. Evaluating the role of genetic variation in the epigenome in health and disease. Mult Scler. 2018;24(6):707-709. doi:10.1177/1352458517751651
De Jager PL. Is the goal of an epigenomic study to determine causality? Mult Scler. 2018;24(7):908-909. doi:10.1177/1352458517750771
Lee JY, De Jager PL. What is the epigenome and is it involved in multiple sclerosis? Mult Scler. 2018;24(3):268-269. doi:10.1177/1352458517750769
Wheeler MA, Quintana FJ. Regulation of Astrocyte Functions in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019;9(1). doi:10.1101/cshperspect.a029009
Hu D, Notarbartolo S, Croonenborghs T, et al. Transcriptional signature of human pro-inflammatory T17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun. 2017;8(1):1600. doi:10.1038/s41467-017-01571-8
Quintana FJ. Astrocytes play a crucial role in the formation and evolution of MS lesions - Commentary. Mult Scler. 2019;25(1):19-20. doi:10.1177/1352458518796693
Kowalec K, Wright GEB, Drögemöller BI, et al. Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis. Nat Genet. 2018;50(8):1081-1085. doi:10.1038/s41588-018-0168-y
Felsky D, Patrick E, Schneider JA, et al. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018;13(1):38. doi:10.1186/s13024-018-0272-6
Manousaki D, Dudding T, Haworth S, et al. Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. Am J Hum Genet. 2017;101(2):227-238. doi:10.1016/j.ajhg.2017.06.014
Quintana FJ, Prinz M. A gut feeling about multiple sclerosis. Proc Natl Acad Sci U S A. 2017;114(40):10528-10529. doi:10.1073/pnas.1714260114